methylthiovinblastine
Small moleculeexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2008 (NCT00724100)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- methylthiovinblastine dihydrochloride
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00724100 | Phase 1 | Sep 1, 2008 | Albany Molecular Research, Inc., Harvard University, Westat, Yeshiva University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Albany Molecular Research, Inc. | For profit | 1 | 1 | 1 | 2008 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Westat | For profit | 1 | 0 | 1 | 2008 |
| Yeshiva University | Academic/Hospital | 1 | 0 | 1 | 2008 |
4 organizations
Page 1 / 1